Variant report

Variant	esv2764078
Chromosome Location	chr8:6791559-6812249
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr8:6804991-6805097	A549	lung:	n/a	chr8:6805026-6805037
2	CEBPB	chr8:6805017-6805075	HepG2	liver:	n/a	chr8:6805026-6805037
3	CEBPB	chr8:6805035-6805075	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr8:6792440-6792590	BE2_C	brain:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
5	CTCF	chr8:6807222-6807310	LNCaP	prostate:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
6	CTCF	chr8:6811229-6811298	GM19240	blood:	n/a	n/a
7	CTCF	chr8:6807154-6807434	K562	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
8	CTCF	chr8:6792377-6792603	K562	blood:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
9	CTCF	chr8:6807200-6807350	GM12868	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
10	CTCF	chr8:6811212-6811289	GM19238	blood:	n/a	n/a
11	CTCF	chr8:6807140-6807290	GM12867	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
12	CTCF	chr8:6792420-6792570	WERI-Rb-1	eye:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
13	CTCF	chr8:6792499-6792508	GM10266	blood:	n/a	n/a
14	CTCF	chr8:6792432-6792561	Hela-S3	cervix:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
15	CTCF	chr8:6807220-6807370	HEK293	kidney:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
16	CTCF	chr8:6792460-6792610	GM12875	blood:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
17	CTCF	chr8:6807207-6807333	GM10248	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
18	CTCF	chr8:6811220-6811370	GM12878	blood:	n/a	n/a
19	CTCF	chr8:6811180-6811330	GM12874	blood:	n/a	n/a
20	CTCF	chr8:6807600-6807750	GM12878	blood:	n/a	n/a
21	CTCF	chr8:6811180-6811330	HepG2	liver:	n/a	n/a
22	CTCF	chr8:6792427-6792521	NHEK	skin:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
23	CTCF	chr8:6807104-6807366	GM19238	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
24	CTCF	chr8:6792420-6792570	HCT-116	colon:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
25	CTCF	chr8:6811170-6811322	GM12878	blood:	n/a	n/a
26	CTCF	chr8:6807129-6807344	Fibrobl	skin:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
27	CTCF	chr8:6792413-6792567	MCF-7	breast:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
28	CTCF	chr8:6811237-6811257	GM20000	blood:	n/a	n/a
29	CTCF	chr8:6807118-6807355	MCF-7	breast:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
30	CTCF	chr8:6807142-6807359	Hela-S3	cervix:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
31	CTCF	chr8:6792460-6792610	HCT-116	colon:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
32	CTCF	chr8:6807160-6807310	GM12873	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
33	CTCF	chr8:6807274-6807348	GM13976	blood:	n/a	n/a
34	CTCF	chr8:6807200-6807350	Hela-S3	cervix:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
35	CTCF	chr8:6807120-6807270	HepG2	liver:	n/a	chr8:6807254-6807270 chr8:6807258-6807268
36	CTCF	chr8:6792400-6792550	A549	lung:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
37	CTCF	chr8:6792500-6792650	GM12864	blood:	n/a	n/a
38	CTCF	chr8:6807059-6807485	K562	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
39	CTCF	chr8:6807180-6807330	GM12873	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
40	CTCF	chr8:6807120-6807270	GM12873	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268
41	CTCF	chr8:6811160-6811310	GM12871	blood:	n/a	n/a
42	CTCF	chr8:6792420-6792570	GM12872	blood:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
43	CTCF	chr8:6807120-6807270	GM12871	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268
44	CTCF	chr8:6807100-6807250	GM12866	blood:	n/a	n/a
45	CTCF	chr8:6792389-6792594	Gliobla	brain:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
46	CTCF	chr8:6807160-6807310	GM12866	blood:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
47	CTCF	chr8:6811120-6811270	NB4	blood:	n/a	n/a
48	CTCF	chr8:6792380-6792530	GM12871	blood:	n/a	chr8:6792493-6792514 chr8:6792491-6792509 chr8:6792492-6792508
49	CTCF	chr8:6807140-6807290	A549	lung:	n/a	chr8:6807254-6807270 chr8:6807258-6807268 chr8:6807253-6807271 chr8:6807255-6807276
50	CTCF	chr8:6811140-6811290	GM12873	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:6795162-6795212	HAEpiC	amniotic membrane:	n/a
2	chr8:6793506-6793556	HRPEpiC	eye:	n/a
3	chr8:6795162-6795212	HAEpiC	amniotic membrane:	n/a
4	chr8:6793506-6793556	HRPEpiC	eye:	n/a
5	chr8:6795980-6796030	HUVEC	blood vessel:	n/a
6	chr8:6795980-6796030	SK-N-SH	brain:	n/a
7	chr8:6796902-6796952	T-47D	breast:	n/a
8	chr8:6793506-6793556	Hela-S3	cervix:	n/a
9	chr8:6795980-6796030	HPAEpiC	pulmonary alveolar:	n/a
10	chr8:6795980-6796030	HEK293	kidney:	embryo
11	chr8:6796618-6796668	HUVEC	blood vessel:	n/a
12	chr8:6795162-6795212	A549	lung:	n/a
13	chr8:6795162-6795212	AG10803	skin:	n/a
14	chr8:6793506-6793556	AG04449	skin:	fetal
15	chr8:6795980-6796030	IMR90	lung:	fetal
16	chr8:6796902-6796952	RPTEC	kidney:	n/a
17	chr8:6795980-6796030	GM19239	blood:	n/a
18	chr8:6795162-6795212	NT2-D1	testis:	n/a
19	chr8:6794872-6794922	HCPEpiC	choroid plexus:	n/a
20	chr8:6793506-6793556	ovcar-3	ovarian:	n/a
21	chr8:6793506-6793556	Caco-2	colon:	n/a
22	chr8:6796902-6796952	HIPEpiC	eye:	n/a
23	chr8:6796902-6796952	AG09309	skin:	n/a
24	chr8:6796902-6796952	SKMC	muscle:	n/a
25	chr8:6796176-6796226	SK-N-SH_RA	brain:	n/a
26	chr8:6796618-6796668	AG04450	lung:	fetal
27	chr8:6795162-6795212	GM12892	blood:	n/a
28	chr8:6796618-6796668	U87	brain:	n/a
29	chr8:6794872-6794922	HNPCEpiC	eye:	n/a
30	chr8:6796618-6796668	K562	blood:	n/a
31	chr8:6795980-6796030	HepG2	liver:	n/a
32	chr8:6794872-6794922	SKMC	muscle:	n/a
33	chr8:6796176-6796226	LNCaP	prostate:	n/a
34	chr8:6793506-6793556	SK-N-SH	brain:	n/a
35	chr8:6796618-6796668	NHBE	bronchial:	n/a
36	chr8:6794872-6794922	HMEC	breast:	n/a
37	chr8:6796176-6796226	GM12878	blood:	n/a
38	chr8:6795162-6795212	HCPEpiC	choroid plexus:	n/a
39	chr8:6794872-6794922	HAEpiC	amniotic membrane:	n/a
40	chr8:6796176-6796226	H1-hESC	embryonic stem cell:	embryo
41	chr8:6796902-6796952	AoSMC	blood vessel:	n/a
42	chr8:6796618-6796668	SK-N-SH	brain:	n/a
43	chr8:6796176-6796226	AG09309	skin:	n/a
44	chr8:6796902-6796952	HRPEpiC	eye:	n/a
45	chr8:6796902-6796952	IMR90	lung:	fetal
46	chr8:6796902-6796952	HRCEpiC	kidney:	n/a
47	chr8:6796176-6796226	IMR90	lung:	fetal
48	chr8:6795162-6795212	HMEC	breast:	n/a
49	chr8:6795980-6796030	HNPCEpiC	eye:	n/a
50	chr8:6795980-6796030	PFSK-1	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr8:6796114..6798602-chr8:6803030..6805863,2	K562	blood:
2	chr8:6698096..6698895-chr8:6806928..6807708,2	K562	blood:
3	chr8:6810171..6811870-chr8:6814020..6816721,2	K562	blood:
4	chr8:6775337..6778035-chr8:6790742..6792474,2	K562	blood:
5	chr8:6796114..6798602-chr8:6803030..6805863,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DEFA4-1	chr8:6808950-6809121	NONHSAT124800
2	lnc-DEFA4-1	chr8:6808248-6808360	NONHSAT124800

Variant related genes	Relation type
DEFA8P	TF binding region
DEFA4	TF binding region
DEFA8P	CpG island
DEFA4	CpG island

Extended variants
information (count: 1306 )
Associated
traits (count: 137 )

Variant overlapped rSNPs/rCNVs (count:1306 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2702863	chr8:6791559-6791560	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs2702864	chr8:6791576-6791577	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs562381936	chr8:6791577-6791578	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs13262140	chr8:6791601-6791602	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs548911692	chr8:6791602-6791603	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs117842967	chr8:6791605-6791606	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs528106330	chr8:6791625-6791626	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs551037341	chr8:6791645-6791646	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs368374502	chr8:6791646-6791647	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs80157953	chr8:6791649-6791650	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs537213000	chr8:6791676-6791677	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs551165197	chr8:6791691-6791692	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs567818564	chr8:6791699-6791700	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs2738106	chr8:6791715-6791716	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs188212391	chr8:6791720-6791721	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs73195968	chr8:6791747-6791748	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs573259139	chr8:6791760-6791761	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs180735423	chr8:6791778-6791779	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs76545915	chr8:6791795-6791796	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs185995383	chr8:6791805-6791806	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs13261705	chr8:6791840-6791841	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs118073035	chr8:6791845-6791846	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs573541048	chr8:6791851-6791852	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs142774534	chr8:6791857-6791858	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs559248855	chr8:6791876-6791877	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs528047761	chr8:6791891-6791892	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs147352135	chr8:6791898-6791899	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs564788973	chr8:6791911-6791912	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs548540281	chr8:6791924-6791925	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs2738105	chr8:6791940-6791941	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs189726321	chr8:6791949-6791950	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs550453033	chr8:6791960-6791961	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs567842328	chr8:6791971-6791972	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs530352139	chr8:6791974-6791975	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs547293584	chr8:6791983-6791984	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs567194192	chr8:6791996-6791997	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs144914575	chr8:6792000-6792001	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs181339236	chr8:6792008-6792009	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs144821340	chr8:6792014-6792015	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs148591643	chr8:6792018-6792019	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs142899391	chr8:6792020-6792021	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs2702865	chr8:6792058-6792059	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs542432724	chr8:6792084-6792085	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs552812047	chr8:6792091-6792092	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs558557166	chr8:6792101-6792102	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs190483884	chr8:6792103-6792104	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs183448746	chr8:6792111-6792112	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs558022717	chr8:6792138-6792139	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs564896971	chr8:6792171-6792172	Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs530467016	chr8:6792215-6792216	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:137)

Disease	PMID	Source
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	21364760	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Cancer	20164919	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Bladder cancer	21909424	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Cognitive impairment	21505072	CNVD
Breast cancer	17142309	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:6785800-6798800	Enhancers	Primary neutrophils fromperipheralblood	blood
2	chr8:6789200-6791800	Weak transcription	Fetal Thymus	thymus
3	chr8:6789400-6791600	Weak transcription	Thymus	Thymus
4	chr8:6791400-6793000	Flanking Active TSS	Dnd41	blood
5	chr8:6791600-6792800	Enhancers	Thymus	Thymus
6	chr8:6791800-6792000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
7	chr8:6791800-6793200	Enhancers	Fetal Thymus	thymus
8	chr8:6792000-6792200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
9	chr8:6792200-6792800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
10	chr8:6792200-6792800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr8:6792400-6793800	Enhancers	Fetal Brain Male	brain
12	chr8:6793000-6798000	Enhancers	Dnd41	blood
13	chr8:6793200-6793600	Weak transcription	Fetal Thymus	thymus
14	chr8:6793600-6793800	Enhancers	Fetal Thymus	thymus
15	chr8:6793800-6800200	Weak transcription	Fetal Thymus	thymus
16	chr8:6794400-6794600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr8:6794600-6829200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr8:6795600-6796200	Enhancers	GM12878-XiMat	blood
19	chr8:6796200-6796400	Enhancers	Primary B cells from cord blood	blood
20	chr8:6796200-6797200	Weak transcription	GM12878-XiMat	blood
21	chr8:6796400-6796600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
22	chr8:6796400-6797400	Weak transcription	Primary B cells from cord blood	blood
23	chr8:6796600-6797600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
24	chr8:6796600-6797800	Enhancers	Primary hematopoietic stem cells	blood
25	chr8:6796600-6797800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
26	chr8:6796600-6797800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr8:6796600-6797800	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
28	chr8:6796800-6797000	Enhancers	Spleen	Spleen
29	chr8:6796800-6798000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
30	chr8:6797200-6797400	Enhancers	GM12878-XiMat	blood
31	chr8:6797400-6797800	Enhancers	Primary B cells from cord blood	blood
32	chr8:6798000-6799600	Weak transcription	Dnd41	blood
33	chr8:6799600-6802800	Enhancers	Dnd41	blood
34	chr8:6799800-6800400	Enhancers	HMEC	breast
35	chr8:6800000-6800200	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
36	chr8:6800200-6803200	Enhancers	Fetal Thymus	thymus
37	chr8:6800200-6804000	Enhancers	Primary neutrophils fromperipheralblood	blood
38	chr8:6800800-6801400	Weak transcription	Spleen	Spleen
39	chr8:6800800-6802800	Enhancers	Thymus	Thymus
40	chr8:6801000-6801400	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
41	chr8:6801000-6801800	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
42	chr8:6801000-6802400	Enhancers	GM12878-XiMat	blood
43	chr8:6801400-6801600	Enhancers	Spleen	Spleen
44	chr8:6801600-6808800	Weak transcription	Spleen	Spleen
45	chr8:6802000-6802400	Enhancers	H1 Cell Line	embryonic stem cell
46	chr8:6802800-6805000	Weak transcription	Dnd41	blood
47	chr8:6802800-6806400	Weak transcription	Thymus	Thymus
48	chr8:6803200-6806400	Weak transcription	Fetal Thymus	thymus
49	chr8:6804000-6804400	Weak transcription	Primary neutrophils fromperipheralblood	blood
50	chr8:6804400-6812400	Enhancers	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links